Biomarkers of kidney disease

Clinical applications for biomarkers include monitoring illness activity, diagnosing it, managing molecularly targeted therapies, and monitoring therapy response. Glomerular filtration rate (GFR) continues to be the ideal indicator of renal health. Kidney damage atoms and lipocalin associated with neutrophil gelatinase are thought to be useful biomarkers in plasma and urine to assess the severity and prognosis of Chronic Kidney Disease.

  • Decompensated heart failure

Related Conference of Biomarkers of kidney disease

November 28-29, 2022

20th International Conference on Nephrology, Urology and Therapeutics

Singapore City, Singapore
December 18-19, 2022

19th International Conference on Nephrology and Hypertension

Barcelona, Spain
February 09-10, 2023

Global Summit on Nephrology, Urology and Kidney Transplantation

Zurich, Switzerland
April 27-28, 2023

24th Global Nephrologists Meet

Rome, Italy
May 15-16, 2023

19th World Nephrology Conference

Singapore City, Singapore
May 16-17, 2023

13th International Conference on Nephrology and Kidney Diseases

Singapore City, Singapore
September 11-12, 2023

8th World Kidney Congress

Paris, France
October 25-26, 2023

11th World Congress on Epidemiology & Public Health

Vancouver, Canada
November 13-14, 2023

27th European Nephrology Conference

Barcelona, Spain

Biomarkers of kidney disease Conference Speakers

Recommended Sessions

Related Journals

Are you interested in